Swedish Healthtech Stock News

Vestum FY 2025 earnings snapshot Vestum (OM:VESTUM) has wrapped up FY 2025 with fourth quarter revenue of SEK 975 million and a loss of SEK 93 million, which translated to EPS of SEK 0.25. Over recent periods, the company has seen quarterly revenue range from SEK 359 million in Q4 2024 to SEK 1,019 million in Q3 2024, while EPS has moved between SEK 0.06 in Q3 2025 and SEK 0.45 on a trailing 12 month basis in Q3 2024. This leaves investors weighing revenue traction against consistently...

Meko (OM:MEKO) has wrapped up FY 2025 with Q4 revenue of SEK4.6b and a basic EPS loss of SEK0.20, alongside trailing twelve month revenue of SEK18.4b and EPS of SEK0.65 that highlight how thin earnings have become. Over recent periods the company has seen quarterly revenue move in a tight band between SEK4.5b and SEK4.8b, while basic EPS has swung from a Q1 profit of SEK0.86 to small losses in Q2 and Q4. This frames a year where the top line held steady but profitability stayed under...

In early February 2026, Mycronic reported its fourth-quarter and full-year 2025 results, with quarterly sales of SEK 2,021 million and annual net income of SEK 1.56 billion, while also issuing 2026 net sales guidance of SEK 8.25 billion and announcing a replacement Prexision 8 Evo order worth US$21–24 million from an Asian customer. The board’s decision to raise the annual dividend to SEK 3.25 per share alongside softer quarterly earnings and fresh mask-writer demand highlights how Mycronic...

Genovis AB (publ.) (OM:GENO) has wrapped up FY 2025 with fourth quarter revenue of 40.999 million SEK and basic EPS of 0.10 SEK, while the trailing twelve months show revenue of 132.945 million SEK and EPS of 0.36 SEK. These figures help set the tone for how the market will read the results. The company has seen quarterly revenue move from 28.9 million SEK in Q4 2024 to 40.999 million SEK in Q4 2025, with EPS over the same quarters shifting from 0.07 SEK to 0.10 SEK. Investors will be...

Devyser Diagnostics (OM:DVYSR) has wrapped up FY 2025 with fourth quarter revenue of 72 million SEK and EPS of 0.82 SEK, putting a clean set of numbers in front of investors off a share price of 102.6 SEK. Over recent periods the company has seen revenue move from 48.7 million SEK in Q3 2024 to 64.2 million SEK in Q4 2024 and then to 72 million SEK in Q4 2025. Quarterly EPS has swung from a loss of 1.41 SEK in Q3 2024 and 0.19 SEK in Q4 2024 to a profit of 0.82 SEK in Q4 2025, setting up a...

Nyab (OM:NYAB) has wrapped up FY 2025 with fourth quarter revenue of €154.6m, net income of €9.0m and basic EPS of €0.01, against a backdrop of 12 month revenue of €547.6m and EPS of €0.03. Over recent periods the company has seen quarterly revenue move from €93.8m in Q3 2024 to €150.3m in Q3 2025 and from €116.5m in Q4 2024 to €154.6m in Q4 2025. Basic EPS shifted from €0.0094 and €0.0130 in those prior quarters to €0.0119 and €0.01. Investors therefore have a clear run of top line and EPS...

AQ Group (OM:AQ) has wrapped up FY 2025 with fourth quarter revenue of SEK 2.5b and basic EPS of 1.83 SEK, putting fresh numbers behind a share price of SEK 182. Looking back over recent periods, the company has seen quarterly revenue move from SEK 2.1b in Q4 2024 to SEK 2.3b in Q1 2025, SEK 2.3b in Q2, SEK 2.1b in Q3 and SEK 2.5b in Q4. Basic EPS tracked from 1.69 SEK to 1.81 SEK, 2.06 SEK, 1.68 SEK and 1.83 SEK over the same stretch, setting up a results season where investors are likely to...

Nederman Holding (OM:NMAN) has wrapped up FY 2025 with fourth quarter revenue of SEK 1.5b and basic EPS of 1.86 SEK, setting a clear snapshot of where the business stands as investors assess the latest full year picture. The company has seen quarterly revenue move from SEK 1.62b in Q4 2024 to SEK 1.50b in Q4 2025, with basic EPS shifting from 2.49 SEK to 1.86 SEK over the same period. Trailing twelve month revenue sits at SEK 5.78b and EPS at 7.8 SEK, giving investors a wider lens on earnings...

Fresh off its FY 2025 results, Lindab International (OM:LIAB) reported Q4 revenue of about SEK3.1b and basic EPS of SEK0.52, while trailing twelve month figures show revenue of roughly SEK12.9b and EPS of SEK9.86 on net income of SEK760m that followed a much weaker prior year when net income was SEK315m. Over the past few quarters the company has seen quarterly revenue move between SEK3.1b and SEK3.3b, with basic EPS ranging from a loss of SEK2.25 in Q4 2024 to SEK5.19 in Q3 2025. FY 2025...

NIBE Industrier (OM:NIBE B) has just wrapped up FY 2025 with Q4 revenue of SEK11.0b and basic EPS of SEK0.39, putting fresh numbers on the table for investors watching the heating and energy efficiency space. Over the past few quarters, the company has seen revenue move from SEK9.7b in Q1 2025 to SEK11.0b in Q4, while quarterly EPS shifted from SEK0.19 to SEK0.39 against a backdrop of trailing twelve month EPS of SEK1.13. With earnings over the last year growing much faster than sales and...

Volati (OM:VOLO) FY 2025 earnings snapshot Volati (OM:VOLO) has just wrapped up FY 2025 with Q4 revenue of SEK2.0b and basic EPS of SEK0.44, capping off a year where trailing twelve month revenue reached SEK8.4b and EPS came in at SEK3.30. Over the last six quarters the company has seen quarterly revenue move between SEK1.92b and SEK2.32b while basic EPS has ranged from SEK0.13 to SEK1.47. This gives investors a clear view of how earnings have tracked alongside fairly stable top line levels...

Ambea (OM:AMBEA) has wrapped up FY 2025 with Q4 revenue of SEK4.4b and basic EPS of SEK1.56, against a trailing twelve month EPS of SEK7.95 on revenue of SEK16.2b. This frames the latest quarter in the context of a full year of consistent operations. Over recent periods the company has seen quarterly revenue move from SEK3.6b in Q1 2025 to SEK4.1b in Q3 2025 and then SEK4.4b in Q4 2025, while basic EPS has ranged from SEK1.13 to SEK3.83 across those quarters. This gives investors a clearer...

Yubico (OM:YUBICO) FY 2025 earnings snapshot Yubico (OM:YUBICO) has wrapped up FY 2025 with Q4 revenue of 548.3 million SEK and basic EPS of 0.04 SEK, setting the tone for a year where trailing 12 month revenue came in at 2.2 billion SEK and basic EPS was 1.49 SEK. The company has seen quarterly revenue move between 499.1 million SEK and 623.1 million SEK over the past year, with basic EPS ranging from 0.04 SEK to 0.74 SEK. Trailing 12 month EPS and net income have tracked alongside 12 month...

Swedencare (OM:SECARE) has wrapped up FY 2025 with Q4 revenue of SEK684.8 million and basic EPS of SEK0.10, setting a clear snapshot of where the business stands heading into 2026. The company has seen quarterly revenue move from SEK664.9 million and EPS of SEK0.15 in Q4 2024 to SEK684.8 million and EPS of SEK0.10 in Q4 2025, while trailing twelve month revenue sits at SEK2.7 billion with EPS of SEK0.35, giving investors a fuller view of recent performance. With a trailing net margin of 2.4%...

Verisure (OM:VSURE) FY 2025 Earnings Snapshot Verisure (OM:VSURE) has wrapped up FY 2025 with fourth quarter revenue of €964.7 million and a basic EPS loss of €0.12, while trailing 12 month figures show revenue of about €3.7 billion and a basic EPS loss of €0.30. Over the past year, the company has seen revenue move from €870.2 million in Q4 2024 to €964.7 million in Q4 2025, while quarterly EPS stayed in loss making territory, shifting from a €0.07 loss per share in Q4 2024 to a €0.12 loss...

Neobo Fastigheter (OM:NEOBO) has wrapped up FY 2025 with fourth quarter revenue of SEK232 million and basic EPS of SEK0.12, alongside quarterly net income of SEK17 million. Over the past few quarters, the company has seen revenue move from SEK228 million in Q4 2024 to between SEK230 million and SEK236 million through 2025. Quarterly EPS ranged from a loss of SEK0.21 in Q2 2025 to SEK0.43 in Q3 2025 and SEK0.12 in Q4 2025. This puts investor attention on how efficiently that top line is now...

ADDvise Group (OM:ADDV A) has wrapped up FY 2025 with Q4 revenue of SEK 431.7 million and EPS of SEK 0.01, against a backdrop of trailing twelve month revenue of SEK 1,642.7 million and EPS of SEK 0.01. Over recent quarters the company has seen revenue move from SEK 405.9 million and EPS of SEK 0.059 in Q3 2024 to SEK 424.5 million with EPS of SEK 0.129 in Q1 2025, SEK 396.9 million with an EPS loss of SEK 0.143 in Q2, and SEK 363.7 million with EPS of SEK 0.092 in Q3. This sets up a picture...

BioGaia (OM:BIOG B) has just wrapped up FY 2025 with fourth quarter revenue of SEK440.6 million and EPS of SEK0.98, capping a year in which trailing twelve month revenue reached about SEK1.5 billion and EPS came in at SEK3.29. The company has seen quarterly revenue move from SEK364.8 million in Q4 2024 to SEK440.6 million in Q4 2025, while EPS shifted from SEK0.81 to SEK0.98 over the same period. Investors are now weighing those headline figures against a trailing net profit margin of 21.6%...

Stille (OM:STIL) closed out FY 2025 with fourth quarter revenue of SEK 174.9 million and basic EPS of SEK 3.37, setting the tone for how the full year is being judged. Over recent periods, the company has seen quarterly revenue range from SEK 124.7 million to SEK 174.9 million and basic EPS move from SEK 0.10 in Q3 2025 to SEK 3.37 in Q4 2025, while trailing twelve month EPS stood at SEK 6.20 on revenue of SEK 567.6 million. With a trailing net margin of 9.8% and a clear focus on...

If you are looking at EQT and wondering whether the current share price still offers value, this article will walk you through what the numbers actually say about the stock. The share price last closed at SEK 290.30, with returns of 2.0% over 7 days, a 19.4% decline over 30 days, and returns of 20.7% over 3 years and 21.8% over 5 years that give useful longer term context. Recent coverage of EQT has focused on how the stock's shorter term pullback sits against its longer term record. This...

Camurus AB reported its fourth-quarter and full-year 2025 results, with full-year sales rising to SEK 2,265.38 million and net income to SEK 735.57 million, while issuing 2026 guidance for revenues of SEK 2.60–2.90 billion and operating result of SEK 0.90–1.20 billion. Alongside these results, Camurus highlighted 2025 milestones including EU and UK approvals for Oxyesa in acromegaly and progress in long-acting metabolic therapies, underlining how its product pipeline and regulatory traction...

Investment AB Latour (OM:LATO B) has wrapped up FY 2025 with Q4 revenue of SEK7.4b and basic EPS of SEK2.50, while the trailing twelve months show revenue of SEK28.1b and EPS of SEK7.69 against a backdrop of weaker earnings compared with the prior year and a lower net margin of 17.5% versus 23.8%. Over recent quarters, revenue has moved from SEK7.0b in Q4 2024 to SEK7.4b in Q4 2025, with quarterly EPS shifting from SEK2.29 to SEK2.50 as the twelve month EPS line eased from SEK9.65 to SEK7.69...

What recent performance says about Embracer Group (OM:EMBRAC B) Embracer Group (OM:EMBRAC B) has seen its share price move sharply in different directions, with a 19% gain over the past week and a 38% decline over the past 3 months. This places recent momentum in contrast with a weaker medium term trend. See our latest analysis for Embracer Group. At a share price of SEK54.47, Embracer Group’s sharp 18.7% 7 day share price return comes after a weaker stretch, with the 1 year total shareholder...

As global markets navigate a period of mixed performance, with technology stocks facing challenges and value-oriented segments gaining traction, investors are keenly observing the shifts in economic indicators such as cooling U.S. labor data and fluctuating manufacturing activity. In this context, identifying undervalued stocks can be particularly appealing as they may offer potential opportunities for growth amidst the broader market volatility and sector rotations.